NCT01438177View on ClinicalTrials.gov

Chloroquine in Combination With VELCADE and Cyclophosphamide for Relapsed and Refractory Multiple Myeloma

PHASE2TerminatedINTERVENTIONAL
Enrollment

11

Participants

Timeline

Start Date

October 31, 2011

Primary Completion Date

February 28, 2014

Study Completion Date

February 28, 2014

Conditions
Multiple Myeloma
Interventions
DRUG

Velcade

DRUG

Cyclophosphamide

DRUG

Chloroquine

Trial Locations (1)

10016

NYU Cancer Institute, New York

Sponsors
All Listed Sponsors
collaborator

Millennium Pharmaceuticals, Inc.

INDUSTRY

lead

NYU Langone Health

OTHER